간경변 치료제 시장 점유율 분석 및 기회 [2025-2031]
Liver Cirrhosis Therapeutics Drugs Market Report Analysis
Liver Cirrhosis Therapeutics Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Gilead Sciences, Inc
- Intercept Pharmaceuticals, Inc
- Dova Pharmaceuticals
- GlaxoSmithKline Plc
- Regeneron Pharmaceuticals
- Mylan N.V
- Sanofi S.A
- Teva Pharmaceutical Industries Ltd
- F. Hoffmann-La Roche Ltd
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
By 종류
- C형간염 관련 간경변증
- 알코올성 간경변증
- 원발성 경화성 담관염
- 원발성 담즙성 간경변증
- 기타
By 병기 유형
- 대상성 간경변증
- 비대상성 간경변증
By 약물 유형
- 우르소데옥시콜산
- 오베티콜산
- 아자티오프린
- 콜히친
- 기타
By 투여경로
- 경구
- 정맥주사
- 기타
Get Free Sample For